SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-013467
Filing Date
2005-03-29
Accepted
2005-03-29 17:24:32
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-5492_110k.htm 10-K 2333550
2 EX-10.29 a05-5492_1ex10d29.htm EX-10.29 29552
3 EX-10.30 a05-5492_1ex10d30.htm EX-10.30 70006
4 EX-10.31 a05-5492_1ex10d31.htm EX-10.31 58375
5 EX-23.1 a05-5492_1ex23d1.htm EX-23.1 2516
6 EX-31.1 a05-5492_1ex31d1.htm EX-31.1 10665
7 EX-31.2 a05-5492_1ex31d2.htm EX-31.2 9307
8 EX-32 a05-5492_1ex32.htm EX-32 6744
9 GRAPHIC g54921dcimage002.gif GRAPHIC 17845
  Complete submission text file 0001104659-05-013467.txt   2541082
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 05710650
SIC: 2834 Pharmaceutical Preparations